Legislation requiring transparency of health care prices may not lead to lower drug and hospital-related prices, two opponents of such measures said. Dr. Robert Graboyes, a researcher at George Mason University, said that price transparency could lead to collusion between hospitals that results in higher prices. He instead advocated for increasing competition. Dr. Keith Smith, an anesthesiologist at the Surgery Center of Oklahoma, said that unnecessary government intervention has created inefficiencies and driven up prices.
The rising cost of health care is an urgent problem in the United States, but health care price transparency is not the way to solve it, two health care professionals told the Daily Caller News Foundation.
Dr. Robert Graboyes, a researcher and academic at George Mason University, told the Daily Caller News Foundation that adding transparency to health care pricing “a number of problems” that could ultimately lead to an increase in costs for consumers.
Graboyes said that implementing health care price transparency could lead to tacit collusion among hospitals and pharmaceutical companies due to how the industry is structured. Basically, if providers knew what their competitors charged, a provider with lower rates could raise its prices to match the higher one with little risk of losing business, he